Performance of the stock
The 52-week high and low of this share are Rs 226.00 and Rs 23.80 respectively. The shares were listed on BSE in 1995 and on NSE in 2016.
The road ahead: Focus on IVD business
The company also thinks that its IVD (in vitro diagnostics) business is continuing to grow, though it could be modest in the near term. However, in the long-term, this segment may become a major growth engine for the company. The management of Cupid expects to see better earnings from the IVD business after regulatory approvals, new product launches and commercialisation accelerate. However, it must be reiterated that investing in penny stocks is too risky unless you are a seasoned investor who can understand the nuances of the business of the company and the movement of the stock market.
(Disclaimer: This article is only meant to provide information. News9 does not recommend buying or selling shares or subscriptions of any IPO, Mutual Funds, precious metals, commodity, REITs, InvITs and any form of alternative investment instruments and crypto assets.)
The stock behind this massive wealth creation is Cupid Ltd., a well-known manufacturer of personal healthcare and wellness products.
Over the last five years, this stock transitioned from an obscure penny stock trading at just ₹2.45 per share (in July 2021) to hovering around the ₹212 - ₹213 mark on the National Stock Exchange (NSE).
This monumental shift represents a massive multibagger return of over 8,600%. A lump-sum investment of ₹1 lakh made five years ago and held consistently would be valued at approximately ₹87 lakh today.
Performance Breakdowns: Growth Over Time
Cupid Ltd. has repeatedly outpaced market benchmarks across multiple timeframes, showing that its growth wasn't just a one-off spike:
1 Year: An investment of ₹1 lakh grew to roughly ₹8.4 lakh (delivering an ~870% return).
3 Years: The stock delivered an astronomical 8,522% return, turning ₹1 lakh into roughly ₹84 lakh.
Year-to-Date (YTD): The stock has more than doubled, showing over 100% gains within the current calendar year alone.
1 Month: Short-term momentum remains highly aggressive, surging over 41% in a month (turning ₹1 lakh into ₹1.33 lakh).
What is Driving the Rally?
Unlike many penny stocks that spike purely on speculation, Cupid’s rally has been supported by significant operational expansions and stronger corporate guidance:
Record Financial Guidance: The company announced an optimistic outlook for Q1 FY27, projecting quarterly revenues to cross ₹150 crore—marking one of the strongest individual quarters in its corporate history.
Upward Revision of Target Revenues: Driven by strong visibility across both domestic and international pipeline orders, management revised its full-year FY27 revenue target upward by 10% from ₹600 crore to exceed ₹660 crore.
The IVD Expansion Engine: The company is aggressively expanding into the In Vitro Diagnostics (IVD) business. While near-term growth here is conservative due to regulatory gestation periods, commercialization and new product approvals are expected to make this a dominant long-term growth driver.
A Note of Caution on Penny Stocks:
While Cupid Ltd. serves as a classic textbook success story of multibagger wealth generation, penny stocks carry extreme volatility, lower liquidity, and a high risk of capital loss. Thorough research into a company’s corporate governance, debt levels, and actual revenue streams is crucial before investing.
No comments:
Post a Comment